Regulatory Open Forum

there is no substitute for a timely assessment of the situation and effective strategies to minimize regulatory failure and shorten time to market. The strategy for regulatory approval could be just as unique as the product itself.

#gap analysis #Drugs #Clinical testing and trials #Combination Products #Orphan #regulatory intelligence #Vaccines #Biologics #Biotechnology #Cell and gene therapy #Regulatory strattegy